#United States #Frisco #Orthopedic Implants #4WEB Medical #TRUSS Implant Technology

4WEB Medical: A Leap into the Future of Orthopedic Implants

In a significant advancement for orthopedic surgery, 4WEB Medical has unveiled the potential of its proprietary TRUSS Implant Technology™ after a study conducted at the prestigious McKay Orthopaedic Research Laboratory, affiliated with the University of Pennsylvania. This innovative technology is set to redefine therapeutic implants, enhancing healing processes through scientifically validated methods.

The study, titled "Therapeutic Implants Mechanobiologic Enhancement of Osteogenic, Angiogenic, and Myogenic Responses in Human Mesenchymal Stem Cells on 3D-Printed Titanium Truss," has received approval for publication in the journal Advanced Healthcare Materials (AHM). This journal is celebrated for showcasing high-impact research in medical devices and materials that contribute to improved health outcomes. The results of this study are being hailed as a transformative moment for implant technology, showcasing not only the efficacy of the implants but also their unique biological effects when successfully integrated into patients.

Jessee Hunt, the founder and CEO of 4WEB Medical, expressed his enthusiasm, stating, "We are extremely pleased with the results of this study. The evolution of our TRUSS Implant Technology continues to gain momentum. The findings demonstrate that our truss implant retains differentiation as the sole therapeutic option available. The structural mechanics of our design effectively converts physiological load into therapeutic strain at the surgical site, which significantly amplifies osteogenic activity—essential for successful surgical outcomes. This advance offers surgeons and their patients the optimum opportunity for recovery while the biological fusion process is underway. Welcome to the era of therapeutic implants!"

The groundbreaking findings noted in the October edition of AHM highlighted that orthopedic implants employing Advanced Structural Designs stimulate therapeutic biological responses. Specifically, research indicated that the TRUSS Implant Technology fosters a beneficial interaction between hierarchical surface roughness and the overarching macro truss architecture, illustrating a remarkable 30% increase in osteogenic activity against traditional approaches solely reliant on surface roughness.

Dr. Andrew Sama, Co-Chief of HSS Spine in New York, remarked, "The research conducted by UPENN on 4WEB's truss implant marks the first instance I have encountered where the implant elicits a therapeutic effect independent of chemical contributions and extends beyond conventional passive features like surface roughness."

4WEB Medical is committed to leveraging this research to perform a series of additional studies aimed at decreasing the high procedural costs associated with current BMP and cellular biologics. The company posits that the inherent therapeutic properties of the TRUSS Implant Technology, when combined with economical biologic graft materials, can yield a more financially viable solution with faster fusion rates.

For further information, the comprehensive study is accessible online via AHM Journal.

About UPENN McKay Orthopaedic Research Laboratory

Under the co-direction of Dr. Robert Mauck, the UPENN McKay Orthopaedic Research Laboratory is highly focused on musculoskeletal regeneration, employing diligent mechanical and molecular analyses. This technique enriches the understanding of native tissue structure and function, facilitating advances in engineered constructs through targeted technological developments. Their work, which significantly relies on adult mesenchymal stem cells and innovative cell scaffolding technologies, receives vital support from esteemed agencies, including the National Institutes of Health and the Department of Defense, highlighting the collaborative network fostering groundbreaking healthcare solutions.

About 4WEB Medical

Founded in 2008 in Dallas, Texas, 4WEB Medical has carved a niche in the orthopedic field with its commitment to pioneering implant technology, utilizing its patented TRUSS Implant Technology™. This company was the first to secure 510(k) clearance for an implant crafted through 3D printing, marking a milestone in medical device innovation. The technology is characterized by its truss-based implants, uniquely designed to convert physiological loads into therapeutic strains at the surgical site, actively enhancing healing throughout the recovery journey. This proprietary design forms the backbone of their diverse range of interbody implants tailored for both cervical and lumbar spine surgeries, as well as a range of implants for upper and lower extremities, catering to the specific needs of patients suffering from tumor-related conditions, trauma, or significant bone deficiencies.